KEAP1 and neoplasm: We found a good separation of NRF2 gene signature score distribution between KEAP1 mutated group and KEAP1 wild type group (wilcox single sided test pvalue < 0.05), suggesting that KEAP1 mutation drives activation of NRF2 pathway in LUAD tumor (Fig 4B).